Deciding on the Duration of Dual Antiplatelet Therapy-When the Choice Between 2 Evils Is Still Evil.
作者信息
Valgimigli Marco, Gargiulo Giuseppe
机构信息
Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Department of Cardiology, Bern University Hospital, Bern, Switzerland2Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
出版信息
JAMA Cardiol. 2017 May 1;2(5):488-489. doi: 10.1001/jamacardio.2017.0125.
PMID:28297004
Abstract
摘要
相似文献
1
Deciding on the Duration of Dual Antiplatelet Therapy-When the Choice Between 2 Evils Is Still Evil.
JAMA Cardiol. 2017 May 1;2(5):488-489. doi: 10.1001/jamacardio.2017.0125.
2
Formal comment to Toyota et al.: Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration.致丰田等人的正式评论：冠状动脉支架植入术后短期与长期双重抗血小板治疗（DAPT）疗程的比较：DAPT研究与其他9项评估DAPT疗程的试验之间的对比
PLoS One. 2017 Sep 20;12(9):e0184513. doi: 10.1371/journal.pone.0184513. eCollection 2017.
3
Perioperative antiplatelet management in patients with coronary artery stenting.冠状动脉支架置入患者的围手术期抗血小板管理
Hosp Pract (1995). 2012 Apr;40(2):118-30. doi: 10.3810/hp.2012.04.977.
4
The Optimal Duration of Dual-Antiplatelet Therapy After Coronary Stenting: Shorter or Longer?冠状动脉支架置入术后双联抗血小板治疗的最佳持续时间：较短还是较长？
J Am Coll Cardiol. 2017 Oct 24;70(17):2208-2210. doi: 10.1016/j.jacc.2017.07.796.
5
American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons.美国心脏病学会/美国心脏协会2016年双联抗血小板治疗（DAPT）重点更新：对外科医生的启示
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1276-1278. doi: 10.1016/j.jtcvs.2016.04.047. Epub 2016 Apr 20.
6
Bleeding and Mortality With Dual Antiplatelet Therapy: The Rashomon Effect.双联抗血小板治疗的出血与死亡率：罗生门效应
J Am Coll Cardiol. 2017 Apr 25;69(16):2023-2025. doi: 10.1016/j.jacc.2017.02.052.
7
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.冠状动脉支架植入术后2型糖尿病患者三联抗血小板治疗与双联抗血小板治疗的有效性和安全性比较：一项随机对照试验的系统评价和荟萃分析
BMC Cardiovasc Disord. 2015 Oct 9;15:118. doi: 10.1186/s12872-015-0114-1.
8
Dual Antiplatelet Therapy and Bleeding-Related Deaths.双重抗血小板治疗与出血相关死亡
J Am Coll Cardiol. 2017 Sep 5;70(10):1304-1305. doi: 10.1016/j.jacc.2017.05.076.
9
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.双联抗血小板治疗的疗程：针对2016年美国心脏病学会/美国心脏协会关于冠心病患者双联抗血小板治疗疗程重点更新指南的系统评价：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2016 Sep 6;134(10):e156-78. doi: 10.1161/CIR.0000000000000405. Epub 2016 Mar 29.
10
Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.急性冠状动脉综合征冠状动脉支架置入术后优化双联抗血小板治疗的策略
J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):347-355. doi: 10.1177/1074248416683048. Epub 2016 Dec 21.
引用本文的文献
1
Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy.近期发生急性心肌梗死并接受抗血栓治疗的瑞典患者中，缺血性和出血性事件与死亡率的相关性。
JAMA Netw Open. 2022 Aug 1;5(8):e2220030. doi: 10.1001/jamanetworkopen.2022.20030.
2
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.双联抗血小板治疗持续时间：协调不一致之处。
Drugs. 2017 Oct;77(16):1733-1754. doi: 10.1007/s40265-017-0806-1.
Zotero 插件